Close Menu

lawsuit

The matter is of particular importance since UMass is the only one of the four organizations to which the IP is assigned to have licensed it to companies other than Alnylam.

Although the suit was first filed last summer, the courtroom showdown had been brewing for years.

PerkinElmer withdrew the patent infringement suit only a week after filing it.

The agreement settles a suit brought in Canada last month by PerkinElmer against MDS, seeking to block the transfer of a joint venture with MDS Analytical Technologies to Danaher.

Myriad would like the court to decide the ACLU's anti-gene-patenting suit ahead of the case going to trial, while the USPTO would like to the court to dismiss the claims against it.

The former CEO of Visigen, which was acquired in 2008 by Invitrogen, has alleged breach of contract, fraud, and negligent representation, all of which have been denied by Life Technologies.

Boram Pharm claims Life Tech's baculovirus expression system infringes its patent.

The settlement, which will be funded by insurance proceeds, relates to a lawsuit filed in November by Sequenom's shareholders alleging mishandling of data surrounding the company's SEQureDx test.

The suit, filed by Alnylam and Max Planck against the University of Massachusetts, MIT, and the Whitehead Institute for Biomedical Research, is set to go to trial Feb. 22.

GE Healthcare charges in its complaint that kits and instruments sold by Beckman Coulter Genomics based on the Agencourt Solid Phase Reversible Immobilization, or SPRI, technology "contain instructions to use the products in a manner that infringes one or more claims of the '231 and/or '946 patents."

Pages

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.